Celyad Oncology SA (EBR:CYAD)
0.2900
-0.0100 (-3.33%)
May 22, 2026, 5:28 PM CET
Celyad Oncology Employees
As of December 31, 2025, Celyad Oncology had 5 total employees, including 4 full-time and 1 part-time employees. The number of employees decreased by 14 or -73.68% compared to the previous year.
Employees
5
Change (1Y)
-14
Growth (1Y)
-73.68%
Revenue / Employee
€4,200
Profits / Employee
€166,000
Market Cap
12.98M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 5 | -14 | -73.68% | 4 | 1 |
| Dec 31, 2024 | 19 | 0 | - | 17 | 2 |
| Dec 31, 2023 | 19 | -19 | -50.00% | 17 | 2 |
| Dec 31, 2022 | 38 | -63 | -62.38% | 35 | 3 |
| Dec 31, 2021 | 101 | 10 | 10.99% | 95 | 6 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UCB SA | 9,765 |
| argenx SE | 1,863 |
| Onward Medical | 137 |
| European Medical Solutions | 127 |
| Hyloris Pharmaceuticals | 55 |
| Oxurion NV | 11 |
| BioSenic | 7 |
Celyad Oncology News
- 7 weeks ago - Celyad Oncology Annual report: H2 2025 - Filings
- 8 months ago - Celyad Oncology Earnings release: H1 2025 - Filings